[A Case of Multidomain Integrated Treatment Strategy 
for Complex Primary Pulmonary Sarcomatoid Carcinoma].

Xiaosen Huo, Hang Zou, Yanyan Dong, Yuan Li, Lingjie Bian, Lei Li, Hongwu Wang
{"title":"[A Case of Multidomain Integrated Treatment Strategy \u2029for Complex Primary Pulmonary Sarcomatoid Carcinoma].","authors":"Xiaosen Huo, Hang Zou, Yanyan Dong, Yuan Li, Lingjie Bian, Lei Li, Hongwu Wang","doi":"10.3779/j.issn.1009-3419.2024.102.04","DOIUrl":null,"url":null,"abstract":"<p><p>Pulmonary sarcomatoid carcinoma (PSC) is a rare and highly malignant tumor, which includes the following five pathologic types: pleomorphic carcinoma, spindle cell carcinoma, giant cell carcinoma, carcinosarcoma and pulmonary blastoma. The onset of PSC is occult with non-specific clinical symptoms and signs. The clinical manifestations include irritating cough, bloody sputum, dyspnea, chest pain and so on, which are closely related to the growth and invasion site of the tumor. PSC tends to metastasize early, so most patients are already in local advanced stage or advanced stage with a median survival of 9 months at the time of hospital visit. A patient with primary PSC which led to 90% stenosis in central airway was treated by combined method of vascular and tracheoscopic intervention in our respiratory center. This treatment prolonged the patient's survival time and got a satisfactory effect at 19-month follow-up after surgery. Herein we report the case for clinical reference.\u2029.</p>","PeriodicalId":39317,"journal":{"name":"中国肺癌杂志","volume":"27 2","pages":"157-160"},"PeriodicalIF":0.0000,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10918249/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国肺癌杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3779/j.issn.1009-3419.2024.102.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Pulmonary sarcomatoid carcinoma (PSC) is a rare and highly malignant tumor, which includes the following five pathologic types: pleomorphic carcinoma, spindle cell carcinoma, giant cell carcinoma, carcinosarcoma and pulmonary blastoma. The onset of PSC is occult with non-specific clinical symptoms and signs. The clinical manifestations include irritating cough, bloody sputum, dyspnea, chest pain and so on, which are closely related to the growth and invasion site of the tumor. PSC tends to metastasize early, so most patients are already in local advanced stage or advanced stage with a median survival of 9 months at the time of hospital visit. A patient with primary PSC which led to 90% stenosis in central airway was treated by combined method of vascular and tracheoscopic intervention in our respiratory center. This treatment prolonged the patient's survival time and got a satisfactory effect at 19-month follow-up after surgery. Herein we report the case for clinical reference.
.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[复杂原发性肺肉瘤样癌的多领域综合治疗策略一例]。
肺肉瘤样癌(PSC)是一种罕见的高度恶性肿瘤,包括以下五种病理类型:多形性癌、纺锤形细胞癌、巨细胞癌、癌肉瘤和肺爆炸瘤。肺间质瘤发病隐匿,临床症状和体征无特异性。临床表现包括刺激性咳嗽、血痰、呼吸困难、胸痛等,与肿瘤的生长和侵犯部位密切相关。PSC 往往转移较早,因此大多数患者已处于局部晚期或晚期,在医院就诊时的中位生存期为 9 个月。本院呼吸中心曾为一名原发性 PSC 患者实施了血管和气管镜联合介入治疗,导致患者中央气道 90% 狭窄。这种治疗方法延长了患者的生存时间,术后 19 个月随访效果满意。我们在此报告该病例,供临床参考。.
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
中国肺癌杂志
中国肺癌杂志 Medicine-Pulmonary and Respiratory Medicine
CiteScore
1.40
自引率
0.00%
发文量
5131
审稿时长
14 weeks
期刊介绍: Chinese Journal of Lung Cancer(CJLC, pISSN 1009-3419, eISSN 1999-6187), a monthly Open Access journal, is hosted by Chinese Anti-Cancer Association, Chinese Antituberculosis Association, Tianjin Medical University General Hospital. CJLC was indexed in DOAJ, EMBASE/SCOPUS, Chemical Abstract(CA), CSA-Biological Science, HINARI, EBSCO-CINAHL,CABI Abstract, Global Health, CNKI, etc. Editor-in-Chief: Professor Qinghua ZHOU.
期刊最新文献
[A Case Report of Successful Control of Refractory Tumor Fever 
in Lung Adenocarcinoma with Interleukin-6 Antibody Tocilizumab]. [Research Progress on Glycolytic Reprogramming and Lactylation Crosstalk in Tumors]. [Clinical Application of the International System for Serous Fluid Cytopathology 
in the Stratified Diagnosis of Lung Cancer-associated Serous Effusions]. [Expression, Prognostic and Functional Analysis of SRSF Family Proteins 
in Non-small Cell Lung Cancer]. [Role of Receptor Tyrosine Kinase AXL in Cancer Targeted Therapy Drug Resistance].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1